Pharmaceutical / Drug Definition :
Relaxes vascular smooth muscles of arteries and arterioles, causing peripheral vasodilation and decreasing peripheral vascular resistance. These actions decrease blood pressure and increase heart rate, stroke volume, and cardiac output.
FDA Label Requirements and Exceptions
Hydralazine Hydrochloride
FDA Import Information
Hydralazine Hydrochloride
FDA Detentions
Hydralazine Hydrochloride (Hydralazine Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Hydralazine Hydrochloride (Hydralazine Hydrochloride Suppliers)
- Processors Hydralazine Hydrochloride
- Repackers Hydralazine Hydrochloride
- Relabelers Hydralazine Hydrochloride
- Exporters Hydralazine Hydrochloride
- Importers Hydralazine Hydrochloride
For more information about Hydralazine Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
